Volume 24, Issue 4 , Pages 457-461, August 2010
Challenges in clinical trial design in inflammatory arthritis☆
The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward.
Keywords: rheumatoid arthritis, clinical trials, comparative effectiveness research, ethics
To access this article, please choose from the options below
☆ RA: Trial design crisis in the midst of an abundance of therapeutic options. Or – If we don't change direction soon, we will end up where we are going.
PII: S1521-6942(09)00144-2
doi:10.1016/j.berh.2009.11.008
© 2009 Published by Elsevier Inc.
Volume 24, Issue 4 , Pages 457-461, August 2010
